Ascendis Health Limited announced that in order to ensure leadership continuity and stability following the resignation of the group's CEO, Mark Sardi, with effect from December 31, 2021, the board announced that Andrew Marshall, the group's independent non-executive chairman, has been appointed as acting CEO with effect from January 1, 2022. Andrew is a highly experienced CEO, having served in this capacity at Oceana Group Limited and Nampak Limited for ten years and five years, respectively. He previously served as acting CEO of Ascendis Health from May 2019 to October 2019. Mark Sardi has made himself available for the six months to June 2022 to advise the company and facilitate a smooth leadership transition. The board has commenced the process for the recruitment and appointment of a permanent CEO for the group.